{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:03:34Z","timestamp":1789401814912,"version":"build-2803163510"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dilated cardiomyopathy (DCM) is a common hereditary cardiac disease in Doberman Pinschers. Early myocardial changes can be detected using cardiac biomarkers such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI). The Vcheck V200 (Bionote) is a point-of-care immunofluorescence-based assay for in-clinic measurement of these markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the diagnostic performance of NT-proBNP and cTnI measured with the Vcheck V200 point-of-care assays for detecting different stages of DCM in Doberman Pinschers and to compare Vcheck cTnI results with those obtained using a laboratory-based IDEXX cTnI assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>A total of 453 serum samples from 345 privately owned, purebred Doberman Pinschers in Germany were analyzed. Dogs were clinically classified into five stages (A, last normal, B1, B2, and C) based on echocardiographic and electrocardiographic findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective longitudinal study included physical examination, echocardiography, 24-h Holter monitoring, and biomarker analysis. NT-proBNP and cTnI concentrations were measured using the Vcheck V200 assay. In a subset of 358 samples, cTnI concentrations were additionally measured using the IDEXX assay. Diagnostic performance was evaluated using receiver operating characteristic curve analysis, and agreement between cTnI assays was assessed using Bland\u2013Altman analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NT-proBNP and cTnI concentrations were significantly higher in dogs with DCM than in healthy controls. For NT-proBNP measured with Vcheck, a cutoff of \u2265580\u202fpmol\/L yielded 76.6% sensitivity and 83.1% specificity (AUC 0.845). For cTnI measured with Vcheck, a cutoff of \u22650.21\u202fng\/mL achieved 71.0% sensitivity and 78.3% specificity (AUC 0.809). The IDEXX cTnI assay showed higher diagnostic accuracy, particularly in early-stage disease, including \u201clast normal\u201d dogs. Combining both Vcheck biomarkers increased sensitivity and overall diagnostic performance (AUC 0.886), but specificity was reduced and performance remained lower than that of IDEXX cTnI alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and clinical importance<\/jats:title>\n                    <jats:p>The Vcheck V200 provides a practical and accessible tool for in-clinic biomarker assessment in Doberman Pinschers at risk for DCM. While Vcheck NT-proBNP and cTnI may help identify dogs requiring further cardiac evaluation, the laboratory-based IDEXX cTnI assay showed higher diagnostic accuracy, especially for early-stage detection. Dogs exceeding these biomarker thresholds should undergo comprehensive cardiac evaluation, including echocardiography and 24-h Holter monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2026.1895815","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:11:11Z","timestamp":1789398671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance of Vcheck NT-proBNP and cardiac troponin I assays for detection of dilated cardiomyopathy in Doberman Pinschers"],"prefix":"10.3389","volume":"13","author":[{"given":"Helena","family":"Driessen","sequence":"first","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-University","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Friederich","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-University","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wess","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-University","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1939-1676.2007.tb03058.x","article-title":"A prospective genetic evaluation of familial dilated cardiomyopathy in the Doberman pinscher","volume":"21","author":"Meurs","year":"2007","journal-title":"J Vet Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1939-1676.2010.0479.x","article-title":"Prevalence of dilated cardiomyopathy in Doberman pinschers in various age groups","volume":"24","author":"Wess","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jvc.2017.08.006","article-title":"European Society of Veterinary Cardiology Screening Guidelines for dilated cardiomyopathy in Doberman pinschers","volume":"19","author":"Wess","year":"2017","journal-title":"J Vet Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cvsm.2004.05.009","article-title":"Dilated cardiomyopathy: an update","volume":"34","author":"O'Grady","year":"2004","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1939-1676.2010.0575.x","article-title":"Use of Simpson's method of disc to detect early echocardiographic changes in Doberman pinschers with dilated cardiomyopathy","volume":"24","author":"Wess","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2460\/javma.1997.210.04.505","article-title":"Clinical and pathologic findings in Doberman pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984-1991)","volume":"210","author":"Calvert","year":"1997","journal-title":"J Am Vet Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2460\/javma.1982.181.06.598","article-title":"Congestive cardiomyopathy in Doberman pinscher dogs","volume":"181","author":"Calvert","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1939-1676.1997.tb00474.x","article-title":"Signalment, survival, and prognostic factors in Doberman pinschers with end-stage cardiomyopathy","volume":"11","author":"Calvert","year":"1997","journal-title":"J Vet Internal Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jvc.2021.09.004","article-title":"Screening for dilated cardiomyopathy in dogs","volume":"40","author":"Wess","year":"2022","journal-title":"J Vet Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2460\/ajvr.68.1.42","article-title":"Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations","volume":"68","author":"Oyama","year":"2007","journal-title":"Am J Vet Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2460\/ajvr.72.5.642","article-title":"Evaluation of N-terminal pro-B-type natriuretic peptide as a diagnostic marker of various stages of cardiomyopathy in Doberman pinschers","volume":"72","author":"Wess","year":"2011","journal-title":"Am J Vet Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/jsap.13455","article-title":"Usefulness of cardiac biomarker screening to detect dilated cardiomyopathy in Dobermanns","volume":"63","author":"Dukes-McEwan","year":"2022","journal-title":"J Small Anim Pract"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/vcp.13101","article-title":"Analytical validation of a novel point-of-care immunoassay for canine N-terminal pro-brain natriuretic peptide analysis","volume":"51","author":"Harr","year":"2022","journal-title":"Vet Clin Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","article-title":"Essential biochemistry and physiology of (Nt-pro)Bnp","volume":"6","author":"Hall","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1939-1676.2010.0516.x","article-title":"Cardiac troponin I in Doberman pinschers with cardiomyopathy","volume":"24","author":"Wess","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jvim.15384","article-title":"Evaluation of a high-sensitivity cardiac troponin I assay compared to a first-generation cardiac troponin I assay in Doberman pinschers with and without dilated cardiomyopathy","volume":"33","author":"Kluser","year":"2019","journal-title":"J Vet Internal Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/vcp.70062","article-title":"Analytical validation of a novel point-of-care quantitative immunoassay for feline N-terminal pro-brain natriuretic peptide","volume":"54","author":"Javery","year":"2025","journal-title":"Vet Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/vec.13438","article-title":"Evaluation of a rapid test for point-of-care detection of cardiac troponin I in serum of healthy and diseased dogs and cats","volume":"34","author":"Santarelli","year":"2024","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jvc.2022.01.004","article-title":"Prospective evaluation of the combined value of physical examination and biomarker variables in screening for preclinical dilated cardiomyopathy in Doberman pinschers","volume":"40","author":"Gordon","year":"2022","journal-title":"J Vet Cardiol"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1895815\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:11:11Z","timestamp":1789398671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1895815\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":19,"alternative-id":["10.3389\/fvets.2026.1895815"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1895815","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1895815"}}